Minnesota Ophthalmic Plastic Surgery Specialists

What Minnesota Ophthalmic Plastic Surgery Specialists does

Minnesota Ophthalmic Plastic Surgery Specialists (MOPSS) is a private, single-location medical practice based in Edina, Minnesota, founded in 1990 by Dr. Eric R. Nelson. The practice operates as a division of Infinite Health Collaborative (i-Health), a physician-owned group of independent practices, and is devoted exclusively to oculoplastic and ophthalmic plastic surgery of the eyelids, orbits, tear ducts, and mid-face. As of 2024 it is staffed by four ASOPRS-fellowship-trained, board-certified ophthalmologists (Nelson, Harrison, Baker, Kamboj) and one physician assistant (Isabel Essler, PA-C).

MOPSS delivers a comprehensive surgical and procedural menu split across two segments: cosmetic services — blepharoplasty, forehead/brow lifts, neurotoxin injections (BOTOX, Dysport, Xeomin), facial fillers, and an upcoming resurfacing line — and functional/reconstructive services including ptosis repair, entropion/ectropion repair, DCR (tear duct surgery with a reported 90%+ success rate), benign lesion excision, Mohs reconstruction, orbital mass and trauma surgery, enucleation, blepharospasm treatment, and thyroid eye disease (TEPEZZA) management. Patient engagement runs through a FollowMyHealth portal, Oberd intake forms, and Assort Health–powered online bill pay.

The business model is professional-services fee-for-service. Reimbursement is split between insurance billing (handled under Infinite Health Collaborative via Revo Health) for qualifying functional and reconstructive procedures and direct self-pay for cosmetic consultations and procedures, which must be paid in full one week before surgery. Go-to-market is sales-led and referral-driven: patients self-refer or are referred by ophthalmologists, dermatologists, and other providers, with scheduling by phone or website contact form and marketing conducted through the practice website, Instagram (@mopss_mn), and word-of-mouth. Geographic reach is restricted to the Minneapolis–St. Paul metro via a single Edina clinic, with surgeries performed on-site and at affiliated surgery centers and hospitals.

Name

Minnesota Ophthalmic Plastic Surgery Specialists

Legal name

Minnesota Ophthalmic Plastic Surgery Specialists

Website

https://mopss.com

Company type

Private

Founded year

1990

Operating status

Operating

Short description

Minnesota Ophthalmic Plastic Surgery Specialists is a private, single-location Edina, MN medical practice providing cosmetic and functional oculoplastic surgery of the eyelids, orbits, tear ducts, and mid-face to patients in the Minneapolis–St. Paul metro, delivered by four ASOPRS-trained surgeons and a physician assistant.

Ownership category

akta.pro rank

Product category

Oculoplastic and Ophthalmic Plastic Surgery

NAICS

Offices of Other Health Practitioners (6213)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Oculoplastics & Orbital Surgery (HLAKAKAI)

akta.pro secondary industries

Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO), Ophthalmology Surgery Centers (HLAFAIAF), Plastics / Cosmetic & Dermatologic Surgery Centers (HLAFAIAK), Mohs Surgery & Skin Cancer (Dermatologic Oncology) (HLAKACAD)

Keywords

• Oculoplastic surgery services
• Eyelid surgery specialists
• Facial reconstructive surgery
• Cosmetic eye procedures
• Tear duct surgery

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Surgical Procedures: Revenue from oculoplastic surgeries including blepharoplasty, ptosis repair, brow lifts, orbital surgery, skin cancer reconstruction, and tear duct surgery. Cosmetic fees collected one week prior to surgery; insurance-covered procedures billed separately through Infinite Health Collaborative.
2. Office Consultations and Visits: Revenue from initial consultations, follow-up visits, and cosmetic consultations. Co-payments due at time of service; insurance information required for insurance-covered visits.
3. Injectable Treatments: Revenue from neurotoxin injections (BOTOX, Dysport, Xeomin) and facial fillers. Results typically last up to 4 months for neurotoxins.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Minnesota Ophthalmic Plastic Surgery Specialists (MOPSS) is a single-site medical practice in Edina, Minnesota that provides oculoplastic and ophthalmic plastic surgery for the eyelids, orbits, tear ducts, and mid-face. The practice offers cosmetic procedures (blepharoplasty, brow lifts, neurotoxin/filler injectables), functional procedures (ptosis repair, entropion/ectropion repair, DCR, blepharospasm treatment, thyroid eye disease treatment), and reconstructive procedures (skin cancer and Mohs reconstruction, orbital mass surgery, trauma repair, enucleation). Services are delivered by four ASOPRS-trained board-certified ophthalmologist/oculoplastic surgeons and one physician assistant.

Product overview

Minnesota Ophthalmic Plastic Surgery Specialists (MOPSS) offers a comprehensive range of oculoplastic surgery services specializing in reconstructive, functional, and cosmetic procedures of the eyelids, orbits, tear ducts, and mid-face. The practice operates as a single-location surgical center providing: Cosmetic procedures including Eyelid Surgery (Blepharoplasty), Forehead/Brow Lift, Neurotoxin Injections (BOTOX, Dysport, Xeomin), Facial Fillers, and Resurfacing (upcoming); Functional and reconstructive procedures including Ptosis Repair, Entropion/Ectropion Repair, DCR (blocked tear duct surgery), Benign Eyelid Lesions Treatment, Skin Cancer Surgery with Mohs Reconstruction, Orbital Mass Surgery, Orbital and Eyelid Trauma Treatment, Eye Removal Surgery (Enucleation), Blepharospasm Treatment, and Thyroid Eye Disease Treatment. The practice also provides patient engagement tools including FollowMyHealth patient portal for medical records access and Oberd for patient intake forms.

Differentiator

Problem solved

Functional benefit

Products and services

• Eyelid Surgery (Blepharoplasty) Upper and lower eyelid blepharoplasty and ptosis repair to address heavy, drooping eyelids and reduce bags or puffiness; performed as outpatient surgery in a surgery center or hospital.
• Forehead/Brow Lift Forehead and brow lift procedures to correct drooping or sagging brows, including conventional forehead lift, endoscopic brow lift with Endotine Fixation Devices, indirect brow lift (browpexy), and direct brow lift options.
• Neurotoxin Injections (BOTOX, Dysport, Xeomin) FDA-approved neurotoxin treatments for temporary improvement of moderate to severe frown lines between brows, with results typically seen within days and lasting up to 4 months.
• Facial Fillers Facial filler injections that replace lost volume and hyaluronic acid to restore facial volume and smooth wrinkles and facial folds.
• Ptosis Repair Surgical repair of drooping eyelids by tightening the levator muscle tendon, performed through lid crease incision or internal eyelid incision.
• Entropion/Ectropion Repair Surgical repair of eyelids turning inward (entropion) or outward (ectropion), including tightening of the eyelid and, where required, tissue grafts or implants.
• Dacryocystorhinostomy (DCR) Blocked tear duct surgery that creates a new tear drain opening from the lacrimal sac directly into the nose, with temporary silicone tube or stent placement for 3–6 months; reported greater than 90% success rate in adults.
• Benign Eyelid Lesions Treatment Treatment of benign eyelid lesions including chalazion, stye, and hemangioma, with treatment plans varying based on size, location, and appearance.
• Skin Cancer Surgery and Mohs Reconstruction Surgical excision of skin cancers with reconstruction, including closure of defects created by Mohs Micrographic Surgery performed by dermatologists.
• Orbital Mass Surgery

Quantifiable outcome

• 90%+ success rate for DCR (blocked tear duct) surgery in adults without prior nasal surgery or disease
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

Partnerships

One partnership is on record.

• Senn & SonscoreStrategic or Co-development PartnerSenn & Sons, led by Kim Senn, designed and developed MOPSS's new branding and website. The collaboration involved strategic and creative storytelling to translate the practice's vision into cohesive concepts, imagery, and designs. The resulting website highlights the practice's patient care approach and provides essential information to current and future patients.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Wills Eye Hospital Oculoplastic Surgery Service: Philadelphia-based academic eye hospital with a high-volume oculoplastic surgery service performing reconstructive and cosmetic eyelid, orbital, and tear duct procedures. Comparable in clinical subspecialty and reputation, but operates within a multi-subspecialty academic institution.
• Cleveland Clinic Cole Eye Institute: Academic ophthalmology department with a subspecialized oculoplastic and orbital surgery service. Overlaps with MOPSS on functional and reconstructive eyelid/orbital surgery, but as part of a broader hospital-based ophthalmology portfolio rather than an independent private specialty practice.
• Bascom Palmer Eye Institute: University of Miami-affiliated eye institute consistently ranked among the top US ophthalmology centers, with a dedicated oculoplastic surgery service. Comparable in the oculoplastic sub-specialty and academic leadership, but operates as a broad ophthalmology incumbent rather than a focused private practice.

Direct peers

• TabanMD Oculoplastic Surgery: Beverly Hills-based oculoplastic surgery practice led by Dr. Mehryar Taban, focused exclusively on eyelid, orbital, and facial plastic surgery including cosmetic and reconstructive procedures. Direct peer in domain specialization, patient demographics, and premium private-practice positioning.
• Fante Eye and Face Centre: Oculoplastic surgery practice in Denver, CO led by Dr. Robert Fante, offering eyelid surgery, brow lifts, injectables, and reconstructive procedures. Comparable single-specialty oculoplastic practice serving a similar mix of cosmetic and functional/reconstructive patients.
• TOC Eye and Face: Oculoplastic and facial plastic surgery practice in Austin, TX offering blepharoplasty, brow lifts, injectables, and reconstructive eyelid/orbital surgery. Highly comparable to MOPSS as a single-specialty oculoplastic practice with a similar procedure mix and provider-driven referral model.
• Consultants in Ophthalmic & Facial Plastic Surgery: Oculoplastic and facial plastic surgery practice based in Michigan, performing blepharoplasty, ptosis repair, tear duct surgery, and Mohs reconstruction. Closely comparable to MOPSS in scope, ASOPRS-style specialization, and physician-referral-driven patient acquisition.
• Oculoplastic Surgery Consultants: Oculoplastic and facial plastic surgery practice offering functional and cosmetic eyelid surgery, brow lifts, and reconstructive procedures. Closely comparable to MOPSS in clinical scope and physician-led specialty model.
• Eye Plastic Surgery Associates: Oculoplastic surgery group with multiple Florida locations performing cosmetic and reconstructive eyelid, tear duct, and orbital procedures. Direct competitor in domain and procedure mix, differing primarily through multi-site geographic reach.

Emerging players

• The Larrabee Center for Plastic Surgery: Seattle-based facial plastic surgery center offering blepharoplasty, brow lifts, facelift surgery, and injectables. Partially comparable to MOPSS in cosmetic eyelid and brow procedures but competes on the cosmetic side rather than the functional/reconstructive oculoplastic side.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/mopss_mn

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Minnesota Ophthalmic Plastic Surgery Specialists